Novozymes strengthens and accelerates its BioHealth-business by acquiring a majority stake in Synergia Life Sciences, a leading developer and manufacturer of probiotics and vitamin K2-7
November 30, 2021 04:34 ET
|
Novozymes A/S
Novozymes acquires a majority stake in Synergia Life Sciences Pte. Ltd., a leading player in the field of spore probiotics and vitamin K2-7, for a cash payment of DKK ~1 billion (USD ~150 million)....